BANK OF MONTREAL /CAN/ - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAH1. A total of 19 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$6,719,821
+671882.1%
6,100,000
+813233.3%
0.00%
Q3 2022$1,0000.0%750
-40.0%
0.00%
Q2 2022$1,000
-85.7%
1,250
-77.3%
0.00%
Q1 2022$7,000
-99.4%
5,500
-99.4%
0.00%
-100.0%
Q2 2021$1,193,0001,000,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
CAMDEN ASSET MANAGEMENT L P /CA 40,225,000$40,854,0001.37%
Wellesley Asset Management 15,287$15,583,0001.10%
SSI INVESTMENT MANAGEMENT LLC 4,671,000$4,738,0000.32%
WOLVERINE ASSET MANAGEMENT LLC 21,495,000$21,916,0000.24%
SHENKMAN CAPITAL MANAGEMENT INC 3,206,000$3,255,0000.18%
CAPSTONE INVESTMENT ADVISORS, LLC 22,674,000$23,142,0000.14%
AQR Arbitrage LLC 4,100,000$4,185,0000.09%
Polar Asset Management Partners Inc. 7,000,000$7,164,0000.09%
Calamos Advisors LLC 9,500,000$9,722,0000.04%
PUTNAM INVESTMENTS LLC 7,105,000$7,216,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders